BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...

Ludwig-Maximilians-Universität München-led researchers have induced a greater than 60% reduction in seizure frequency in a ...

Researchers have created a hairlike device for long-term, non-invasive monitoring of the brain's electrical activity. The lightweight and flexible electrode attaches directly to the scalp and delivers ...